Thus, decreased phosphate levels by PA intake may delay the hyperphosphorylation process and influence the formation of phosphorylated tau protein; (iii) In the brain, higher levels of UA, which is one of the purine metabolites that possesses antioxidant properties, may exert neuroprotective actions in AD [50]. The gene discussed is MAPT; the disease is Alzheimer disease.